Mixed pneumococcal-nontypeable haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution

Journal of Infectious Diseases

Volumn 208, Issue 7, 2013, Pages 1152-1160

  Dagan, Ron ^a   Leibovitz, Eugene ^a   Greenberg, David ^a   Bakaletz, Lauren ^b,c   Givon Lavi, Noga ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

chronic; mixed infections; non responsive; nontypeable H. influenzae; otitis media; recurrent; S. pneumoniae

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BODY TEMPERATURE; CHILD; CHRONICITY; CONTROLLED STUDY; CROWDING (AREA); FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYRINGOTOMY; NONHUMAN; OTITIS MEDIA; PATIENT HISTORY OF SURGERY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WINTER; BACTERIUM IDENTIFICATION; CHRONIC; CLASSIFICATION; COMPARATIVE STUDY; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NASOPHARYNX; NON-RESPONSIVE; NONTYPEABLE H. INFLUENZAE; PATHOLOGY; RECURRENT; S. PNEUMONIAE; SEROTYPING;

CHRONIC; MIXED INFECTIONS; NON-RESPONSIVE; NONTYPEABLE H. INFLUENZAE; OTITIS MEDIA; RECURRENT; S. PNEUMONIAE;

BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CHILD, PRESCHOOL; COINFECTION; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; ISRAEL; MALE; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84887314613     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit289     Document Type: Article

References (50)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study. J Infect Dis 1989; 160:83-94
2. Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J 2009; 28:466-71
3. Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J 2000; 19:911-6
4. Pichichero ME, Casey JR, Hoberman A, Schwartz R. Pathogens causing recurrent and difficult-To-Treat acute otitis media, 2003-2006. Clin Pediatr (Phila) 2008; 47:901-6
5. Leibovitz E, Asher E, Piglansky L, et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media Pediatr Infect Dis J 2007; 26:589-92
6. Bakaletz LO. Bacterial biofilms in otitis media: Evidence and relevance. Pediatr Infect Dis J 2007; 26:S17-9
7. Broides A, Dagan R, Greenberg D, Givon-Lavi N, Leibovitz E. Acute otitis media caused by Moraxella catarrhalis: Epidemiologic and clinical characteristics. Clin Infect Dis 2009; 49:1641-7
8. Brockson ME, Novotny LA, Jurcisek JA, McGillivary G, Bowers MR, Bakaletz LO. Respiratory Syncytial Virus Promotes Moraxella catarrhalis-Induced Ascending Experimental Otitis Media. PLoS One 2012; 7: E40088
9. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: A significant pathogen in acute otitis media. Pediatr Infect Dis J 2004; 23:1142-52
10. Thornton RB, Rigby PJ, Wiertsema SP, et al. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr 2011; 11:94
11. Rayner MG, Zhang Y, Gorry MC, Chen Y, Post JC, Ehrlich GD. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998; 279:296-9
12. Brook I, Gober AE. Long-Term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate. J Med Microbiol 2005; 54:553-6
13. Starner TD, Zhang N, Kim G, Apicella MA, McCray PB Jr. Haemophilus influenzae forms biofilms on airway epithelia: Implications in cystic fibrosis. Am J Respir Crit Care Med 2006; 174:213-20
14. De Schutter I, De Wachter E, Crokaert F, et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-Acquired pneumonia: Identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011; 52:1437-44
15. Levy A, Fraser D, Vardi H, Dagan R. Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol 1998; 14:179-86
16. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000; 44:43-50
17. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006; 25:602-7
18. Rovers MM, Glasziou P, Appelman CL, et al. Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: A meta-Analysis of individual patient data. Pediatrics 2007; 119:579-85
19. Rovers MM, Glasziou P, Appelman CL, et al. Antibiotics for acute otitis media: A meta-Analysis with individual patient data. Lancet 2006; 368:1429-35
20. Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-Associated cystic fibrosis pulmonary exacerbations. Chest 2010; 137:852-60
21. Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012; 39:38-45
22. Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, Swords WE. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis 2010; 202: 1068-75
23. Commisso R, Romero-Orellano F, Montanaro PB, Romero-Moroni F, Romero-Diaz R. Acute otitis media: Bacteriology and bacterial resistance in 205 pediatric patients. Int J Pediatr Otorhinolaryngol 2000; 56:23-31
24. Jacoby P, Carville KS, Hall G, et al. Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian Aboriginal and non-Aboriginal children. Pediatr Infect Dis J 2011; 30:480-5
25. Leach AJ, Morris PS. The burden and outcome of respiratory tract infection in Australian and aboriginal children. Pediatr Infect Dis J 2007; 26:S4-7
26. Rasmussen F. Protracted secretory otitis media. The impact of familial factors and day-care center attendance. Int J Pediatr Otorhinolaryngol 1993; 26:29-37
27. Marchant CD, Shurin PA, Turczyk VA, Wasikowski DE, Tutihasi MA, Kinney SE. Course and outcome of otitis media in early infancy: A prospective study. J Pediatr 1984; 104:826-31
28. Ruohola A, Meurman O, Nikkari S, Skottman T, Heikkinen T, Ruuskanen O. The dynamics of bacteria in the middle ear during the course of acute otitis media with tympanostomy tube otorrhea. Pediatr Infect Dis J 2007; 26:892-6
29. Armbruster CE, Hong W, Pang B, et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. MBio 2010; 3:e00102-10. doi:10.1128/mBio.00102.10
30. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296:202-11
31. Hong W, Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun 2007; 75:958-65
32. Weimer KE, Juneau RA, Murrah KA, et al. Divergent mechanisms for passive pneumococcal resistance to beta-lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis 2011; 203:549-55
33. Cope EK, Goldstein-Daruech N, Kofonow JM, et al. Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease. PLoS One 2011; 6:e28523
34. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-And clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424-32
35. Hanage WP, Auranen K, Syrjanen R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: Implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004; 72:76-81
36. Marks LR, Parameswaran GI, Hakansson AP. Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infect Immun 2012; 80:2744-60
37. Tapiainen T, Kujala T, Kaijalainen T, et al. Biofilm formation by Streptococcus pneumoniae isolates from paediatric patients. APMIS 2010; 118:255-60
38. Moscoso M, Garcia E, Lopez R. Biofilm formation by Streptococcus pneumoniae: Role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 2006; 188:7785-95
39. Camilli R, Pantosti A, Baldassarri L. Contribution of serotype and genetic background to biofilm formation by Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2011; 30:97-102
40. Perez-Trallero E, Marimon JM, Larruskain J, Alonso M, Ercibengoa M. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease. Antimicrob Agents Chemother 2011; 55:2729-34
41. Starner TD, Shrout JD, Parsek MR, Appelbaum PC, Kim G. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. Antimicrob Agents Chemother 2008; 52:137-45
42. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: A meta-Analysis. Clin Infect Dis 2010; 51:692-9
43. Sharma SK, Casey JR, Pichichero ME. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis 2011; 204:645-53
44. van den Biggelaar AH, Pomat WS, Phuanukoonnon S, et al. Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy. Pediatr Infect Dis J 2012; 31:243-8
45. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95
46. Palmu AA, Verho J, Jokinen J, Karma P, Kilpi TM. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 2004; 23:732-8
47. Gisselsson-Solen M, Melhus A, Hermansson A. Pneumococcal vaccination in children at risk of developing recurrent acute otitis media-A randomized study. Acta Paediatr 2011; 100:1354-8
48. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis mediarelated health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 2008; 121:253-60
49. Stamboulidis K, Chatzaki D, Poulakou G, et al. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011; 30:551-5
50. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D. Incidence dynamics of culture-proven otitis media 4 years before and 3 years after introduction of pneumococcal conjugate vaccines (PCVs) in southern Israel [abstract 508]. Presented at: IDWeek 2012, San Diego, CA, 17-21 October 2012